MIAMI BEACH — A next-generation, micronet, mesh-covered stent demonstrated improved restoration of blood flow to the heart tissue compared to both bare-metal and drug-eluting stents in heart attack patients undergoing angioplasty, according to the MASTER trial presented for the first time this week at the Transcatheter Cardiovascular Therapeutics (TCT) meeting.